Search NLS News

The US Food and Drug Administration (FDA) has accepted for review the company’s New Drug Application (NDA) for Oclaiz (CAM2029) for the treatment of patients with acromegaly. The FDA has assigned a Prescription Drug User Fee Act (PDUFA) target action date of 21 October 2024. CAM2029 is a novel, octreotide subcutaneous depot designed for once-monthly […]

AlzeCure Pharma has announced that the patent offices in China, India, South Africa, Israel, Hong Kong and Mexico have granted patents covering the company’s clinical drug candidate ACD856, which is being developed against Alzheimer’s and other disorders with cognitive impairment. “This further strengthens the patent portfolio for ACD856 and is an important part of our […]

The European Innovation Council (EIC) has announced that Gedea Biotech has been selected for the EUR 2.5 million EIC Accelerator grant for the continued development and commercialization of pHyph, an antibiotic free treatment for vaginal infections. The funding will accelerate the development of pHyph, bringing this treatment earlier to patients in need, states Gedea Biotech. […]

Vicore Pharma has entered into an exclusive licensing agreement with Nippon Shinyaku to develop and commercialize Vicore’s drug candidate C21 in Japan. Under the terms of the agreement, Vicore will receive an upfront payment of USD 10 million and is entitled to potential development and commercial milestone payments up to a total of USD 275 […]

Center for Translational Research (CTR) expands its portfolio of life science service companies through the establishment of CTC Netherlands BV. CTC Netherlands BV is CTR group’s first company outside of Sweden. The new company will operate a clinical research unit that specializes in early phase patient research and healthy volunteer studies that require invasive procedures. […]

On February 27th the Open up for Innovation event brought together over a 100 representatives from the academia from Umeå University and industry players from both local and national sectors. The event was organized by Umeå Biotech Incubator (UBI), Coalition Umeå 4 Life Science and the Innovation Office at Umeå University. “We have world-class research […]

Researchers at the University of Copenhagen have discovered a network of neurons in the brain of mice that help them make right and left turns. The researchers expect to find a similar right-left circuit in the human brain, and in the future, the discovery may be used in treatment for Parkinson’s disease. The study has […]

The company’s strategic changes include a staff reduction, Cellaviva becoming a wholly owned subsidiary and the GMP facility will have new sources of revenue. NextCell develops the cell therapy drug ProTrans for the treatment of type 1 diabetes. ProTrans is now being evaluated in a clinical trial. In addition, a five year follow-up of previous […]

The Biomedical Center (BMC) will have improved study spaces, greener courtyards, more energy measures, more welcoming entrances and a new clinical training centre. BMC, located in the southern parts of central Uppsala, was built in stages from the late 1960s until 1985. The building has since been fitted with several extensions and today consists of […]

The European Medicines Agency (EMA) has granted Priority Medicines (PRIME) designation to Aurealis Therapeutics’ lead product candidate AUP-16 for the treatment of non-healing Diabetic Foot Ulcers (nhDFU). “With the PRIME status and support by EMA, we aim to expedite the further development of AUP-16 program to bring a novel therapeutic option for patients suffering from […]